Director Luke Evnin reported selling shares of Werewolf Therapeutics, Inc. NASDAQ:HOWL, according to a Form 4 filing with the Securities and Exchange Commission. The stock has recently taken a ...
MPM BioVentures 2014, L.P. and related entities sold a total of 242,890 shares of Werewolf Therapeutics Inc. NASDAQ:HOWL common stock between November 4 and November 6, 2025, for approximately ...
Director Luke Evnin of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) recently sold a total of 199,356 shares of common stock in three separate transactions, netting approximately $251,348. The sale comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback